Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Efficient Production of a Lentiviral System for Displaying Crimean-Congo Hemorrhagic Fever Virus Glycoproteins Reveals a Broad Range of Cellular Susceptibility and Neutralization Ability Publisher Pubmed



Vasmehjani AA1 ; Salehivaziri M2, 3 ; Azadmanesh K4 ; Nejati A1 ; Pouriayevali MH3 ; Gouya MM5 ; Parsaeian M6 ; Shahmahmoodi S1, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, 1417613151, Iran
  2. 2. Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran
  3. 3. Department of Arboviruses and Viral Hemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran, Tehran, Iran
  4. 4. Department of Virology, Pasteur Institute of Iran, Tehran, Iran
  5. 5. National Communicable Disease Control Centre, Ministry of Health and Medical Education, Tehran, Iran
  6. 6. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Food Microbiology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Archives of Virology Published:2020


Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne disease with a mortality rate of up to 50% in humans. To avoid safety concerns associated with the use of live virus in virus neutralization assays and to detect human serum neutralizing antibodies, we prepared lentiviral particles containing the CCHF glycoprotein (lenti-CCHFV-GP). Incorporation of the GP into the lentiviral particle was confirmed by electron microscopy and Western blotting. Lenti-CCHFV-GP was found to be able to infect a wide range of cell lines, including BHK-21, HeLa, HepG2, and AsPC-1 cells. In addition, lenti-CCHFV-GP was successfully used as an alternative to CCHFV for the detection of neutralizing antibodies. Sera collected from CCHF survivors neutralized lenti-CCHFV-GP particles in a dose-dependent manner. Our results suggest that the lenti-CCHFV-GP pseudovirus can be used as a safe tool for neutralization assays in low-containment laboratories. © 2020, Springer-Verlag GmbH Austria, part of Springer Nature.